Vijay Shreedhar serves as Executive at Adamas Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Vijay Shreedhar has executed 8 insider transactions totaling $66.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 24, 2021 involved transacting 186,786 shares valued at $0.
Vijay Shreedhar currently holds 186,786 shares of Adamas Pharmaceuticals Inc (ADMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vijay Shreedhar has been a net seller of ADMS stock. They have purchased $0 and sold $66.6K worth of shares.
Vijay Shreedhar's most recent insider trade was on Nov 24, 2021, when they sold 186,786 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 21, 2021 | ADMS | $32.0K | Sale | 6,200 | $5.16 | Discretionary |
| Mar 22, 2021 | ADMS | $5.8K | Sale | 1,051 | $5.50 | Discretionary |
| Mar 2, 2021 | ADMS | $0 | Award | 75,000 | $N/A | Discretionary |
| Feb 1, 2021 | ADMS | $28.8K | Sale | 4,514 | $6.39 | Discretionary |
| Mar 17, 2020 | ADMS | $0 | Award | 23,750 | $N/A | Discretionary |
| Jun 7, 2019 | ADMS | $0 | Award | 68,750 | $N/A | Discretionary |